Ashanti Dantanarayana

Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency

Vanessa A. Evans, Renée M. van der Sluis, Ajantha Solomon et al. · AIDS · 2018 · 159 citations

Life Sciences, Immunology, Infectious Diseases +16

Impact of Anti–PD-1 and Anti–CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study

Thomas A. Rasmussen, Lakshmi Rajdev, Ajantha Rhodes et al. · Clinical Infectious Diseases · 2021 · 74 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination

Natalie L. Payne, Ashanti Dantanarayana, Guizhi Sun et al. · Cell Adhesion & Migration · 2012 · 73 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Combination Immune Checkpoint Blockade to Reverse HIV Latency

Renée M. van der Sluis, Nitasha Kumar, Rachel D. Pascoe et al. · The Journal of Immunology · 2020 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Diverse effects of interferon alpha on the establishment and reversal of HIV latency

Renée M. van der Sluis, Jennifer M. Zerbato, Jake W. Rhodes et al. · PLoS Pathogens · 2020 · 53 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17